2020
DOI: 10.1111/dth.13492
|View full text |Cite
|
Sign up to set email alerts
|

Generalized bullous fixed drug eruption successfully treated with cyclosporine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(9 citation statements)
references
References 5 publications
(7 reference statements)
0
8
0
Order By: Relevance
“…In this case, cyclosporine was initiated due to the patient's rapidly progressive blistering, severe pain, and extensive body surface area involvement (28%). Cyclosporine was chosen over continuing the prednisone as multiple GBFDE studies have shown that cyclosporine results in rapid cessation of blistering, re-epithelialization of skin, and resolution of lesions with minimal changes in pigmentation [ 11 , 12 , 14 , 22 ]. Due to its minimal side effects when used acutely and the direct mechanism of inhibiting T-cell activation, it has been suggested to be a therapeutic agent for treating FDE superior to prednisone and intravenous immunoglobulin [ 11 ].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…In this case, cyclosporine was initiated due to the patient's rapidly progressive blistering, severe pain, and extensive body surface area involvement (28%). Cyclosporine was chosen over continuing the prednisone as multiple GBFDE studies have shown that cyclosporine results in rapid cessation of blistering, re-epithelialization of skin, and resolution of lesions with minimal changes in pigmentation [ 11 , 12 , 14 , 22 ]. Due to its minimal side effects when used acutely and the direct mechanism of inhibiting T-cell activation, it has been suggested to be a therapeutic agent for treating FDE superior to prednisone and intravenous immunoglobulin [ 11 ].…”
Section: Discussionmentioning
confidence: 99%
“…A further literature search identified 5 adult cases of GBFDE treated with cyclosporine, but no paediatric cases (Table 1 ) [ 11 , 12 , 13 , 14 ]. Variable dosages (100 mg/day, 2 mg/kg/day, or 5 mg/kg/day), routes of administration (oral or intravenous), and durations (5–7 days) were used, reflecting both the heterogeneity of institutional and practitioner preferences and the lack of evidence for use in GBFDE.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Due to increasing reports of severe cases of GBFDE, including the aforementioned study describing a high mortality rate in this condition [43], there has been recent interest in the use of cyclosporine for treatment. Thus far, there have been six cases of GBFDE treated with cyclosporine described in the literature [63][64][65][66][67]. Five of the cases were in adults, and these patients were treated with five to 14 days of cyclosporine, typically at doses of three or five mg/kg daily, with resolution of erythema and cessation of further blistering [63][64][65][66].…”
Section: Treatmentmentioning
confidence: 99%